Showing results (1-10 of 18) with videos related to
Sort By:
Pageof 2
Nucleic Acids Research|July 6, 2010
Subtle gene modification in mouse ES cells: evidence for incorporation of unmodified oligonucleotides without induction of DNA damageMarieke Aarts, Hein te RieleJournal of Cellular and Molecular Medicine|July 25, 2009
Parameters of oligonucleotide-mediated gene modification in mouse ES cellsMarieke Aarts, Hein te RieleCurrent Opinion in Pharmacology|April 20, 2013
Tumour selective targeting of cell cycle kinases for cancer treatmentMarieke Aarts, Spiros Linardopoulos, Nicholas C TurnerNucleic Acids Research|December 5, 2006
Generation of a mouse mutant by oligonucleotide-mediated gene modification in ES cellsMarieke Aarts, Marleen Dekker, Sandra de Vries, et al.Methods in Molecular Biology (Clifton, N.J.)|March 7, 2009
Gene modification in embryonic stem cells by single-stranded DNA oligonucleotidesMarieke Aarts, Marleen Dekker, Rob Dekker, et al.Molecular Cancer Therapeutics|February 13, 2015
Functional Genetic Screen Identifies Increased Sensitivity to WEE1 Inhibition in Cells with Defects in Fanconi Anemia and HR PathwaysMarieke Aarts, Ilirjana Bajrami, Maria T Herrera-Abreu, et al.Cancer Discovery|May 26, 2012
Forced mitotic entry of S-phase cells as a therapeutic strategy induced by inhibition of WEE1Marieke Aarts, Rachel Sharpe, Isaac Garcia-Murillas, et al.Mutation Research|August 2, 2011
Transient suppression of MLH1 allows effective single-nucleotide substitution by single-stranded DNA oligonucleotidesMarleen Dekker, Sandra de Vries, Marieke Aarts, et al.Plos One|February 17, 2016
CDK1 Is a Synthetic Lethal Target for KRAS Mutant TumoursSara Costa-Cabral, Rachel Brough, Asha Konde, et al.Plos One|April 21, 2017
Correction: CDK1 Is a Synthetic Lethal Target for KRAS Mutant TumoursSara Costa-Cabral, Rachel Brough, Asha Konde, et al.Pageof 2